Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia von Kulaksiz, H, Gehrke, S G, Janetzko, A, Rost, D, Bruckner, T, Kallinowski, B, Stremmel, W

Volltext

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin von Berg, Thomas, von Wagner, Michael, Nasser, Samer, Sarrazin, Christoph, Heintges, Tobias, Gerlach, Tilman, Buggisch, Peter, Goeser, Tobias, Rasenack, Jens, Pape, Gerd R., Schmidt, Wolfgang E., Kallinowski, Birgit, Klinker, Hartwig, Spengler, Ulrich, Martus, Peter, Alshuth, Ulrich, Zeuzem, Stefan

Volltext

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals von Dietz, Julia, Peiffer, Kai-Henrik, Hinrichsen, Holger, Buggisch, Peter, Felten, Gisela, Hüppe, Dietrich, Lutz, Thomas, Schott, Eckart, Berg, Christoph, Spengler, Ulrich, von Hahn, Thomas, Berg, Thomas, Vogelmann, R., Giostra, E., Berg, C., Wedemeyer, H., De Gottardi, A., Discher, T., Roeb, E., Wietzke-Braun, P., Herrmann, A., Kodal, A., Löbermann, M., Schulze zur Wiesch, J., Thimme, R., Schattenberg, J., Sprinzl, M., Schmidt, J., Schott, E., Siebler, J., Stauber, R., Schmiegel, W., Stremmel, W., Strey, B., Trautwein, C., Zachoval, R., Angeli, W., Gattringer, H., Genné, D., Hirschi, C., Kanzler, S., Kullig, U., Magenta, L., Menges, M., Niederau, C., Riecken, B., Roth, J., Schöfl, R., Schneider, A., Seelhoff, A., Semela, D., Walter, E., Winzer, T., Abels, W., Audebert, F., Barthel, K., Benninger, J., Bohr, U., Naumann, U., Bruch, H.R., Chirca, C., Dienethal, A., Dietel, P., Dreher, F., Emke, F., Fischer, J., Frederking, D., Frick, B., Goebel, F., Göbel, U., Herder, M., Heuer, S., Höffl, K.H., Hofmann, W.P., John, C., Kallinowski, B., Khaykin, P., Köster, A., Künzig, B., Littman, M., Löhr, H., Lutz, U., Maurer, P., Moritzen, D., Mroß, M., Mundlos, M., Ningel, K., Oelmann, A., Pascher, E., Philipp, A., Rietzler, S., Schmidt, W., Schwenzer, J., Simon, K., Steffens, H., Tacke, W., Thieringer, J., Ullrich, J., Werheid-Dobers, M., Zipf, A.

Volltext

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection von KALLINOWSKI, B, HASEROTH, K, MARINOS, G, HANCK, C, STREMMEL, W, THEILMANN, L, SINGER, M. V, ROSSOL, S

Volltext

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection : the HEP-NET Acute-HCV-II study von WIEGAND, Johannes, BUGGISCH, Peter, WEDEMEYER, Heiner, MANNS, Michael P, BOECHER, Wulf, ZEUZEM, Stefan, GELBMANN, Cornelia M, BERG, Thomas, KAUFFMANN, Wolfgang, KALLINOWSKI, Birgit, CORNBERG, Markus, JAECKEL, Elmar

Volltext

[604] COMPARISON OF A SHORTENED RIBAVIRIN TREATMENT VS A 24 WEEK STANDARD COMBINATION THERAPY IN HCV INFECTED PATIENTS WITH GENOTYPE 2/3 von Kallinowski, B, Stein, K, Boecher, W, Goeser, T, Spengler, U, Link, R, Klinker, H, Bruckner, T, Haiss, P, Buggisch, P

Volltext

812 THE ROLE OF CHOLESTEROL ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN THE TREATMENT OF GENOTYPE-1 INFECTED HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON-ALFA-2A (PEG) AND RIBAVIRI... von Mauss, S, Zehnter, E, Hueppe, D, Kaiser, K, Boeker, K, Lutz, T, Heyne, R, John, C, Moog, G, Schober, A, Pfaff, R, Zipf, A, Racky, S, Lohmeyer, J, Bokemeyer, B, Kallinowski, B, Witthoeft, T, Alshuth, U

Volltext

842 EFFICACY AND TOLERABILITY OF PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN GENOTYPE 4 PATIENTS WITH CHRONIC HEPATITIS C (CHC) UNDER REAL LIFE CONDITIONS von Zehnter, E, Mauss, S, Kaiser, S, Boeker, K, Lutz, T, Heyne, R, John, C, Moog, G, Schober, A, Pfaff, R, Zipf, A, Racky, S, Lohmeyer, J, Bokemeyer, B, Kallinowski, B, Witthoeft, T, Alshuth, U, Hueppe, D

Volltext

[657] POTENTIAL RELEVANCE OF RAPID VIRAL RESPONSE FOR SVR AND OPTIMISATION OF THE TREATMENT OF HEPATITIS C (CHC) WITH PEGINTERFERON o-2a (PEG) AND RIBAVIRIN (RBV) von Zehnter, E, Mauss, S, Boeker, K, Lutz, Th, Racky, S, Schmidt, W, Ulrich, R, Sbrijer, I, Heyne, R, Schober, A, John, C, Hey, K.H, Bokemeyer, B, Kallinowski, B, Moeller, B, Pape, S, Alshuth, U, Hueppe, D

Volltext

[656] THE ROLE OF GLOMERULAR FILTRATION RATE (GFR) FOR TREATMENT WITH PEGINTERFERON ALFA 2a (PEG) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CHC) von Zehnter, E, Mauss, S, Boeker, K, Lutz, Th, Racky, S, Schmidt, W, Ulrich, R, Sbrijer, I, Heyne, R, Schober, A, John, C, Hey, K.H, Bokemeyer, B, Kallinowski, B, Moeller, B, Pape, S, Alshuth, U, Hueppe, D

Volltext

Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? von Kallinowski, B, Knöll, A, Lindner, E, Sänger, R, Stremmel, W, Vollmar, J, Zieger, B, Jilg, W

Volltext

Accelerated Schedule of Hepatitis B Vaccination in Liver Transplant Candidates von Kallinowski, B, Benz, C, Buchholz, L, Stremmel, W

Volltext

Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection von Engler, S., Flechtenmacher, C., Wiedemann, K. H., Gugler, R., Stremmel, W., Kallinowski, B.

Volltext

Clinical impact of hepatitis G virus infection in heart and liver transplant recipients von Kallinowski, B, Seipp, S, Dengler, T, Klar, E, Theilmann, L, Stremmel, W

Volltext

Recombinant hepatitis B vaccine (Engerix-B®): A review of its immunogenicity and protective efficacy against hepatitis B von KEATING, Gillian M, NOBLE, Stuart

Volltext

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks von Manns, M. P., Wedemeyer, H., Singer, A., Khomutjanskaja, N., Dienes, H. P., Roskams, T., Goldin, R., Hehnke, U., Inoue, H.

Volltext

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients von Berg, Christoph P., Peiffer, Kai-Henrik, Discher, Thomas, Berg, Thomas, Kremer, Andreas E., Vogelmann, R., Neumann-Haefelin, C., De Gottardi, A., Gress, M., Hoffmann, D., Kodal, A., Michl, P., Moradpour, D., Chave, J.-P., Rissland, J., Krawczyk, M., Schulze, P., Semela, D., Rockstroh, J., Strassburg, C.P., Siebler, J., Piecha, F., Sprinzl, M., Stauber, R., Strey, B., Steckstor, W., Brockmeyer, N.H., Canbay, A., Wedemeyer, H., Cornberg, M., Wietzke-Braun, P., Willuweit, K., Hilgard, G., Schöfl, R., Heinzow, H., Jussios, A., Kullig, U., Wollschläger, S., Beretta-Piccoli, B. Terziroli, Menges, M., Muehlenberg, K., Pinkernell, M., Reinhardt, L., Riecken, B., Rieke, A., Schneider, A., Schott, E., Stich, A., Stickel, F., Audebert, F., Baermann, C., Benninger, J., Bodtländer, A., Böhm, G., Bokemeyer, B., Bucholz, D., Buggisch, P., Matschenz, K., Busch, N., Chirca, C., Diehl, M., Tal, A.O., Dienethal, A., Dietel, P., Dreck, M., Emke, F., Frederking, D., Glas, M., Göbel, U., Görlitz, B., Hartmann, C., Härter, G., Herder, M., Heuer, S., Seegers, B., Holst, F., Hurst, A., John, C., Khaykin, P., Kochsiek, T., Körfer, A., Littman, M., Löhr, H., Gute, P., Lutz, U., Maurer, P., Mauss, S., Mundlos, M., Naumann, U., Ningel, R., Raddant, R., Riedel, M., Schmidt, W., Seitel, G., Simon, K., Steinmüller, M., Svensson, K., Teubner, K., von Lucadou, A., Zehnter, E.

Volltext

Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication von Muller, Hubert M, Pfaff, Eberhard, Goeser, Tobias, Kallinowski, Birgit, Solbach, Christine, Theilmann, Lorenz

Volltext

Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection von MÖHLER, M, GUTZLER, F, KALLINOWSKI, B, GOESER, T, STREMMEL, W

Volltext

328 Comparison of 48 or 72 weeks of treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive patients with chronic hepatitis C infected w... von Berg, Thomas, Von Wagner, M., Hinrichsen, H., Heintges, T., Buggisch, P., Goeser, T., Rasenack, J., Pape, G.R., Schmidt, W.E., Kallinowski, B., Klinker, H., Spengler, U., Klapperich, B., Popescu, M., Zeuzem, S.

Volltext